1. Home
  2. PFSA vs BFRI Comparison

PFSA vs BFRI Comparison

Compare PFSA & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

N/A

Current Price

$0.10

Market Cap

7.1M

Sector

Health Care

ML Signal

N/A

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.82

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFSA
BFRI
Founded
2009
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
8.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PFSA
BFRI
Price
$0.10
$0.82
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.75
AVG Volume (30 Days)
59.9M
424.7K
Earning Date
02-20-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,164,000.00
Revenue This Year
N/A
$9.70
Revenue Next Year
N/A
$10.97
P/E Ratio
N/A
N/A
Revenue Growth
122.22
5.11
52 Week Low
$0.07
$0.54
52 Week High
$12.76
$1.24

Technical Indicators

Market Signals
Indicator
PFSA
BFRI
Relative Strength Index (RSI) N/A 55.43
Support Level N/A $0.77
Resistance Level N/A $0.86
Average True Range (ATR) 0.00 0.08
MACD 0.00 0.01
Stochastic Oscillator 0.00 83.64

Price Performance

Historical Comparison
PFSA
BFRI

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: